Skip to main content
Euglena Co., Ltd. logo

Euglena Co., Ltd. — Investor Relations & Filings

Ticker · 2931 ISIN · JP3944370000 LEI · 529900OW9QKWU8LU7D52 T Manufacturing
Open in API
Filings indexed 78 across all filing types
Latest filing 2026-03-23 Regulatory Filings
Country JP Japan
Listing T 2931

About Euglena Co., Ltd.

https://www.euglena.jp/en/

Euglena Co., Ltd. is a biotechnology company that pioneered the world's first successful outdoor mass cultivation of the edible microalgae, Euglena. The company's core activities are centered on a "Sustainability First" philosophy. Its Healthcare business develops and markets food and cosmetic products that utilize the 59 rich nutrients found in Euglena to support well-being. The Biofuel business focuses on the research, development, and production of next-generation sustainable fuels derived from sources including microalgae and used cooking oil. The company also actively enters new fields to promote social change and contribute to a sustainable society.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, signed by the CEO and CFO, certifying the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2025
2026-03-23 Japanese
有価証券報告書－第21期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains a formal cover page identifying the company (Euglena Co., Ltd.), the fiscal year (2025), and the regulatory filing requirement under the Financial Instruments and Exchange Act. The presence of extensive XBRL tagging and financial data confirms it is the full annual report rather than an announcement. FY 2025
2026-03-23 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically accompanying a 'Second Quarter Report' (Dai-ni shihanki hokokusho). In the Japanese regulatory context, this is a mandatory attachment to the interim/quarterly financial report, confirming the accuracy of the report's contents. Since it is a formal regulatory filing related to the interim reporting period, it falls under the category of Interim/Quarterly Report (IR).
2025-08-08 Japanese
訂正臨時報告書
M&A Activity Classification · 100% confidence The document is a 'Temporary Report' (臨時報告書) filed by Euglena Co., Ltd. with the Kanto Local Finance Bureau. It details a corporate restructuring event, specifically an absorption-type company split (吸収分割) where a subsidiary takes over a business segment. This type of regulatory filing in Japan, which discloses material corporate events outside of regular financial reporting, falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to external takeovers) or other specialized reports.
2025-08-08 Japanese
半期報告書－第21期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) for the company '株式会社ユーグレナ' (Euglena Co., Ltd.) covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, management analysis (MDA), and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-08 Japanese
訂正臨時報告書
Share Issue/Capital Change Classification · 100% confidence The document is titled "訂正臨時報告書" (Correction Extraordinary Report) and explicitly states in Section 1 that it is being filed pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and Article 19, Paragraph 2, Item 2-2 of the Cabinet Office Ordinance on Disclosure of Corporate Information. The content details the resolution by the Board of Directors to grant stock options (new share warrants) to employees, including the number of options, exercise price, and conditions. This type of filing, which reports on specific corporate actions like employee stock option grants, is typically classified as a filing related to capital structure changes or financing activities. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate fit as it concerns the issuance of new share warrants (stock options) which directly impacts capital structure and financing terms. Although it is a formal regulatory filing, the specific nature of the content (stock options) points more strongly to CAP than the general 'RNS' fallback.
2025-04-25 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.